Fig. 1From: Success stories in genomic medicine from resource-limited countriesEncouraging collaboration between developed and developing/resource-limited countries in the field of genomic medicine. While developing countries will benefit from training opportunities, knowledge transfer, and expanding research networks, developed countries are also likely to benefit through comparative work and multicenter projects involving cases with rare diseases or unique clinical features from well-defined populationsBack to article page